Metacrine To Debut On Nasdaq Tomorrow

San Diego, California-based Metacrine is scheduled to go public on the Nasdaq Global Select Market under the symbol "MTCR" on September 16, 2020.

from RTT - Biotech https://ift.tt/2E0sszM
via IFTTT